Perceived safety and efficacy of nicotine replacement therapies among US smokers and ex-smokers: relationship with use and compliance

被引:120
作者
Shiffman, Saul [1 ,2 ]
Ferguson, Stuart G. [1 ,2 ]
Rohay, Jeffrey [1 ]
Gitchell, Joseph G. [3 ]
机构
[1] Pinney Assoc Inc, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Pinney Assoc Inc, Bethesda, MD USA
关键词
compliance; efficacy; nicotine replacement therapy; safety; smoking cessation;
D O I
10.1111/j.1360-0443.2008.02268.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aim Nicotine replacement therapy (NRT) is effective for smoking cessation, but most smokers try to quit without using it. We examined the impact of misperceptions of NRT safety and efficacy on its use. Design and participants A total of 3203 current and former US smokers completed a national mail-out survey of issues and attitudes related to smoking cessation. Findings Two-thirds (66%) of respondents either agreed that 'Stop-smoking products with nicotine are just as harmful as cigarettes' or were unsure whether the statement was true. These respondents were less likely to have used NRT in the past [ 30% versus 49%; odds ratio (OR) = 0.45, 95% confidence interval (CI): 0.39-0.53] and less likely to consider using NRT during future quit attempts (40% versus 53%; OR = 0.60, 95% CI = 0.51-0.71). Additionally, of the respondents who had used nicotine gum in the past 12 months (n = 407), those who had concerns about the safety of NRT reported using fewer pieces of gum per day during treatment (six versus eight pieces/day; P < 0.05), and were less likely to report that they used the gum for greater than 4 weeks (28.5% versus 46.8%; OR = 0.45, 95% CI: 0.27-0.76). A large proportion of the respondents also stated that they did not believe NRT to be efficacious. Conclusions The findings suggest that many smokers are misinformed about the health risks of NRT and that these misperceptions impede not only the adoption of NRT but also compliance during treatment. Misperception of NRT safety is one barrier to effective use of NRT and probably reduces success in quitting.
引用
收藏
页码:1371 / 1378
页数:8
相关论文
共 24 条
[1]   Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them? [J].
Bansal, MA ;
Cummings, KM ;
Hyland, A ;
Giovino, GA .
NICOTINE & TOBACCO RESEARCH, 2004, 6 :303-310
[2]   Cardiovascular toxicity of nicotine: Implications for nicotine replacement therapy [J].
Benowitz, NL ;
Gourlay, SG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (07) :1422-1431
[3]  
BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
[4]  
Cummings K Michael, 2004, Nicotine Tob Res, V6 Suppl 3, pS333
[5]  
DUPRE D, 2004, MORTALITY EU 1997 19
[6]   Attitudes toward nicotine replacement therapy in smokers and ex-smokers in the general public [J].
Etter, JF ;
Perneger, TV .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :175-183
[7]  
Fiore MC., 2000, TREATING TOBACCO USE
[8]   Ethnic disparities in the use of nicotine replacement therapy for smoking cessation in an equal access health care system [J].
Fu, SS ;
Sherman, SE ;
Yano, EM ;
van Ryn, M ;
Lanto, AB ;
Joseph, AM .
AMERICAN JOURNAL OF HEALTH PROMOTION, 2005, 20 (02) :108-116
[9]  
Garvey A J, 2000, Nicotine Tob Res, V2, P53
[10]   Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial [J].
Gonzales, David ;
Rennard, Stephen I. ;
Nides, Mitchell ;
Oncken, Cheryl ;
Azoulay, Salomon ;
Billing, Clare B. ;
Watsky, Eric J. ;
Gong, Jason ;
Williams, Kathryn E. ;
Reeves, Karen R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (01) :47-55